STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Avant Technologies (OTCQB:AVAI), an AI-focused emerging tech company, has announced a strategic review process aimed at maximizing shareholder value. The company will explore opportunities in the biotechnology sector and evaluate strategic technology alternatives to enhance growth and development. Avant has initiated preliminary discussions with potential partners in both biotech and tech sectors, and is identifying technologies that could complement its future plans. The review may lead to joint ventures, acquisitions, and partnerships with industry leaders. CEO Kenneth L. Waggoner emphasized management and board alignment on this decision, stating their commitment to executing strategic objectives while the review is ongoing.

Loading...
Loading translation...

Positive

  • Initiation of a strategic review process to maximize shareholder value
  • Exploration of new opportunities in the biotechnology sector
  • Preliminary discussions with potential strategic partners in biotech and tech sectors
  • Potential for joint ventures, acquisitions, and partnerships with industry leaders

Negative

  • None.

LAS VEGAS, NV / ACCESSWIRE / September 4, 2024 / Avant Technologies, Inc. (OTCQB:AVAI) ("Avant" or the "Company"), an emerging technology company developing solutions in the artificial intelligence (AI) sector, today announced it will begin exploring new opportunities in the biotechnology sector as part of Avant's strategic review process that is now underway. The process will include reviewing and evaluating strategic technology alternatives that may be available to Avant to further enhance the Company's growth opportunities, development, and prosperity with the goal of maximizing shareholder value.

Avant has commenced preliminary discussions with potential strategic partners in both the biotechnology and technology sectors. The Company is also identifying potential technologies that could be a good fit for Avant's future. Avant expects that its strategic review will lead to an exciting new plan for Avant's future, including potential joint ventures, acquisitions, and partnerships with leaders in the biotechnology and other technology sectors.

"Our management team and the Board of Directors are completely aligned on the decision to begin a strategic review of technology alternatives to maximize shareholder value. We will continue discussions with other companies, industry leaders, and legal advisors to enhance the path forward for Avant and its shareholders," said, Kenneth L. Waggoner, Avant's Chief Executive Officer. "While the review process is ongoing, Avant's management remains committed to executing itsstrategic objectives with the full support of the Board."

About Avant Technologies, Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI

https://www.linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies, Inc.
info@avanttechnologies.com

SOURCE: Avant Technologies, Inc.



View the original press release on accesswire.com

FAQ

What is the purpose of Avant Technologies' (AVAI) strategic review process announced on September 4, 2024?

The strategic review process is intended to maximize shareholder value by exploring new opportunities in the biotechnology sector and evaluating strategic technology alternatives to enhance Avant's growth, development, and prosperity.

What potential outcomes does Avant Technologies (AVAI) expect from its strategic review process?

Avant expects the strategic review to lead to a new plan for the company's future, potentially including joint ventures, acquisitions, and partnerships with leaders in the biotechnology and other technology sectors.

Has Avant Technologies (AVAI) started any discussions as part of its strategic review process?

Yes, Avant has commenced preliminary discussions with potential strategic partners in both the biotechnology and technology sectors, and is identifying potential technologies that could fit with the company's future plans.

How does Avant Technologies' (AVAI) management view the strategic review process announced on September 4, 2024?

According to CEO Kenneth L. Waggoner, the management team and Board of Directors are fully aligned on the decision to begin the strategic review, and remain committed to executing strategic objectives with the Board's full support during the ongoing process.
Avant Technologies Inc

OTC:AVAI

AVAI Rankings

AVAI Latest News

AVAI Latest SEC Filings

AVAI Stock Data

57.80M
108.49M
21.46%
Software - Application
Technology
Link
Lithuania
Vilnius